Rare blood disorder

FDA approves gene therapy for adults with transfusion-dependent beta-thalassemia

The U.S. Food and Drug Administration has approved a new gene therapy for adults living with transfusion-dependent beta-thalassemia, a rare inherited blood disorder that often requires frequent…